PMID: 7023667Jul 15, 1981Paper

Surgery for common epithelial tumors of the ovary

Cancer
J T Wharton, J Herson

Abstract

The objectives of the initial surgical procedure in patients with common epithelial carcinomas of the ovary are determination of the intraabdominal extent of the cancer and the reduction of tumor masses to the smallest residuum before initiating further therapy. Since ovarian cancer is a disease of the entire abdominal cavity, biopsy of selected sites will often detect unsuspected involvement by microscopic foci of metastatic carcinoma. Tumor-reductive surgery resulting in a small tumor residuum before initiating chemotherapy is thought to improve the changes for inducing a complete response. The retroperitoneal operative approach enhances the surgeon's effort to remove tumor bulk. Between July 1, 1972, and September 1, 1978, 104 patients with FIGO Stage III or IV carcinomas of the ovary were treated with melphalan. The conditions of 38 patients were evaluated by second-look laparotomy. This analysis attempts to define tumor-reductive surgery and relates the outcome of the results of the operative procedure to patients treated with melphalan.

References

Apr 1, 1979·American Journal of Obstetrics and Gynecology·J T WhartonM P Hodge
Feb 1, 1978·Cancer·N Einhorn
Jul 28, 1977·The New England Journal of Medicine·R R ReimerR C Young
Feb 1, 1978·The Surgical Clinics of North America·C T Griffiths, A F Fuller
Apr 8, 1976·The New England Journal of Medicine·J S Tobias, C T Griffiths
Sep 1, 1976·Cancer·J P SmithF Rutledge
Jun 1, 1973·American Journal of Obstetrics and Gynecology·C M BagleyV T DeVita
Aug 1, 1974·American Journal of Obstetrics and Gynecology·G B Feldman, R C Knapp
Dec 1, 1972·Cancer·J P SmithJ T Wharton
May 15, 1973·American Journal of Obstetrics and Gynecology·M J WebbT J Williams
Aug 15, 1974·American Journal of Obstetrics and Gynecology·R C Knapp, E A Friedman
Nov 1, 1968·The Journal of Obstetrics and Gynaecology of the British Commonwealth·C N Hudson

❮ Previous
Next ❯

Citations

Dec 1, 1989·Gynecologic Oncology·E W SonnendeckerK A Margolius
Nov 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Benedetti-PaniciR Serafini
Nov 18, 1993·The New England Journal of Medicine·S A Cannistra
Feb 1, 1995·Annals of Medicine·P van Geene, D Luesley
Mar 1, 1992·American Journal of Obstetrics and Gynecology·P G Rose
Dec 1, 1987·Pathology, Research and Practice·J P BaakP Kenemans
Apr 3, 2008·The Surgical Clinics of North America·Nishan Chobanian, Charles S Dietrich
Aug 1, 1991·Gynecologic Oncology·W BarnesG Delgado
Jul 1, 1992·Gynecologic Oncology·R FontanelliE di Re
Dec 1, 1985·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A AkinkugbeV P Mordi
Mar 1, 1989·Baillière's Clinical Obstetrics and Gynaecology·M J Webb
Aug 1, 2006·Gynecologic Oncology·Scott M EisenkopWei-Chien Michael Lin
Jun 28, 2005·Surgical Oncology Clinics of North America·Sarah H Hughes, Michael A Steller
Sep 10, 2003·Hematology/oncology Clinics of North America·Andrew J Li, Beth Y Karlan
Feb 14, 1985·The New England Journal of Medicine·G S RichardsonJ H Nelson
May 1, 1990·The British Journal of Surgery·N A Scott, P F Schofield
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amanda Nickles Fader, Peter G Rose
Oct 15, 1987·Cancer·T ThigpenR McGehee
Jan 2, 2007·Annals of Surgical Oncology·Pierluigi Benedetti PaniciRoberto Angioli
Jan 1, 1984·Journal of Cancer Research and Clinical Oncology·A Pfleiderer
Dec 24, 2002·The Australian & New Zealand Journal of Obstetrics & Gynaecology·John Miller, Anthony Proietto
Jan 1, 1997·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C ScarabelliA Zarrelli
Jul 30, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·C T GriffithsN J Finkler
Jan 1, 1983·Archives of Gynecology·H Pickel
May 11, 1999·Obstetrical & Gynecological Survey·C S ChuJ E Wheeler
Dec 29, 2000·Obstetrical & Gynecological Survey·D NunnsD Ireland
Feb 15, 1994·Hospital Practice·C O Granai
Jan 1, 1987·Archives of Gynecology and Obstetrics·A Pfleiderer
May 1, 1993·Current Problems in Cancer·A Byrne, D N Carney

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.